Prescription RequiredMidostaurin is a targeted cancer medicine used for FLT3-mutated acute myeloid leukaemia and selected forms of advanced systemic mastocytosis. It may be combined with chemotherapy for AML or used according to a specialist treatment plan for mast-cell disorders.
| Generic Name | Midostaurin |
| Strength | 25 mg |
| Manufacturer | Zydus |
| Packing | 28 Capsules |
| Prescribed For | Acute Myeloid Leukemia (AML) |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, Japan, UAE, Saudi Arabia, Qatar, Kuwait, Georgia, Mexico, and many other countries. |
Midostaurin blocks several protein kinases that send signals encouraging abnormal cells to survive and multiply. These include abnormal FLT3 activity in certain forms of acute myeloid leukaemia. Blocking these signals helps control cancer-cell growth and promotes their death.
